This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Best Momentum Stock to Buy for October 2nd
by Zacks Equity Research
ETN, TT and EMR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 2, 2023.
Best Income Stocks to Buy for October 2nd
by Zacks Equity Research
ASC, F and EMR made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 2, 2023.
3 Catalysts for October to Regain Momentum: Top 5 Picks
by Nalak Das
At this stage, it will be prudent to invest in momentum stocks. Five such stocks are: CAT, EMR, CPRT, VRT, PXD.
Here's Why You Should Hold on to Emerson (EMR) Stock for Now
by Zacks Equity Research
Strength across the process and hybrid end markets, improving supply chains and expansion initiatives bode well for Emerson (EMR). The company's shareholder-friendly policies are encouraging.
Emerson Electric (EMR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Emerson Electric (EMR) closed at $100.12, marking a +1.18% move from the previous day.
Why Is EnerSys (ENS) Up 6.9% Since Last Earnings Report?
by Zacks Equity Research
EnerSys (ENS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Emerson Electric (EMR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Emerson Electric (EMR) closed at $97.88, marking a -1.05% move from the previous day.
Emerson Electric (EMR) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Emerson Electric (EMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These 3 Stocks Have Seen Recent Analyst Upgrades
by Derek Lewis
Analysts have recently become bullish on these three stocks, lifting their price targets. Is it time to buy?
Here's Why You Should Hold on to Emerson (EMR) Stock Now
by Zacks Equity Research
Emerson (EMR) is set to benefit from strength in the final control business within the Intelligent Devices business unit. The company's measures to reward its shareholders are encouraging.
Emerson (EMR) to Buy Afag, Boost Factory Automation Portfolio
by Zacks Equity Research
Emerson's (EMR) impending acquisition of Afag boosts the Discrete Automation sub-segment, expanding capabilities in factory automation.
Emerson (EMR) to Acquire Flexim, Expand Automation Portfolio
by Zacks Equity Research
Emerson (EMR) aims to expand its automation portfolio and measurement capabilities through the acquisition of Berlin-based company, Flexim.
3 Dividend Aristocrats Positively Surprising Investors
by Derek Lewis
The bulk of the Q2 season is in the rearview mirror, but the quarterly results from these 3 Dividend Aristocrats shouldn't be ignored.
Zacks Investment Ideas feature highlights: DraftKings, Eli Lilly and Emerson Electric
by Zacks Equity Research
DraftKings, Eli Lilly and Emerson Electric have been highlighted in this Investment Ideas article.
3 Stocks to Buy Following Beat-and-Raise Quarters
by Derek Lewis
All three of these stocks saw buying pressure following better-than-expected results. Should investors ride the earnings momentum?
Emerson (EMR) Beats on Q3 Earnings, Revises 2023 View
by Zacks Equity Research
Emerson's (EMR) Q3 revenues increase 14% year over year, driven by solid segmental performance. The company hiked its adjusted earnings guidance for fiscal 2023.
Compared to Estimates, Emerson Electric (EMR) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Emerson Electric (EMR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Emerson Electric (EMR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Emerson Electric (EMR) delivered earnings and revenue surprises of 18.35% and 1.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Emerson (EMR) Ahead of Earnings?
by Zacks Equity Research
Emerson (EMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
4 Industrial Stocks Poised for a Beat This Earnings Season
by Eshani Haque
Despite demand-softness, improving supply chains and cost-control measures are likely to have aided Q2 earnings of Emerson (EMR), Ingersoll Rand (IR), Illinois Tool (ITW) and Johnson Controls (JCI).
Griffon (GFF) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Griffon's (GFF) Q3 performance is likely to have benefited from higher residential and commercial volumes within HBP, partly offset by reduced consumer demand within CPP unit.
What to Expect From Parker-Hannifin's (PH) Q4 Earnings?
by Zacks Equity Research
Benefits from the Win strategy and contribution from the Meggitt acquisition are likely to have boosted Parker-Hannifin's (PH) Q4 performance.
Eaton (ETN) Gears Up to Release Q2 Earnings: What's in Store?
by Zacks Equity Research
Eaton's (ETN) second-quarter earnings are likely to have benefited from improving end-market conditions and a stable contribution from its organic assets.
Can Ingersoll Rand (IR) Retain Beat Streak in Q2 Earnings?
by Zacks Equity Research
Ingersoll Rand's (IR) Q2 performance is likely to have benefited from solid underlying demand and higher orders across the Industrial Technologies segment.
Tenaris (TS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tenaris' (TS) Q2 performance is likely to have been hurt by lower prices and a reduction in U.S. drilling activity. A decline in raw material and energy costs is expected to have driven earnings.